- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
4503
JPX
Week ended 07 Aug 2026
Weekly Investor Report
Astellas Pharma Inc. · Healthcare · Drug Manufacturers - General
Latest close
2,327 JPY
5.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.6% above the Trend Line and sits at 67.0% of its 52-week range. The latest completed week returned 5.7%, after a 8.6% four-week move. The latest news-sentiment score is 54/100.
Setup score
52
out of 100
Latest Close
2,327 JPY
7 Aug 2026
1W Return
5.7%
latest completed week
4W Return
8.6%
short-term follow-through
12W Return
0.1%
quarterly tape
Trend Breadth
80.8%
42 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
5.7%
Latest completed week; four-week move 8.6%.
Indicator stack
44/45
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
22 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.6% above the Trend Line and sits at 67.0% of its 52-week range. The latest completed week returned 5.7%, after a 8.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2512-week average 0.44
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.25Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 8.6% over four weeks, 0.1% over 12 weeks, and 49.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year42
Trend breadth80.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.53Latest activity-pressure read.
Pressure change61.8%Four-week change in activity pressure.
Leadership-6.62Latest relative-leadership reading.
RS change63.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 22 relevant articles.
4 positive · 16 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.4%Distance below the 52-week high.
13-week volatility2.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+9.6%Week of 27 Mar.
Worst week-10.6%Week of 1 May.
Latest week+5.7%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses8
Sharp losses3
Recent vol2.4%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorJP Healthcare
4-week rank14 / 100
Group average1.5%
Trend breadth29.0%
Trend29.0%active weekly trend signals
MD56.0%positive activity pressure
RS13.0%positive relative leadership
Four-week leaders
IndustryJP Drug Manufacturers - General
4-week rank2 / 8
Group average-0.1%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD50.0%positive activity pressure
RS12.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape49/100
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis17/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.25; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 22 relevant articles.
Q1 2027 Astellas Pharma Inc Earnings Presentation (Japanese) Transcript Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2,327 JPY | 5.7% | 2,312 JPY | 1,703 JPY | -0.53 | -6.62 | 37.8M | Off |
| 31 Jul 2026 | 2,202 JPY | 1.6% | 2,308 JPY | 1,701 JPY | -0.93 | -10.01 | 39.0M | Off |
| 24 Jul 2026 | 2,166 JPY | 0.7% | 2,304 JPY | 1,698 JPY | -1.16 | -11.93 | 26.5M | Off |
| 17 Jul 2026 | 2,151 JPY | 0.4% | 2,300 JPY | 1,696 JPY | -1.26 | -11.95 | 34.4M | Off |
| 10 Jul 2026 | 2,142 JPY | -0.5% | 2,298 JPY | 1,694 JPY | -1.38 | -18.03 | 28.3M | Off |
| 3 Jul 2026 | 2,152 JPY | 0.3% | 2,294 JPY | 1,692 JPY | -1.49 | -19.17 | 5.2M | Off |
| 26 Jun 2026 | 2,145 JPY | -0.0% | 2,288 JPY | 1,690 JPY | -1.49 | -19.11 | 6.2M | Off |
| 19 Jun 2026 | 2,146 JPY | 0.3% | 2,281 JPY | 1,688 JPY | -1.32 | -21.34 | 7.2M | Off |
| 12 Jun 2026 | 2,140 JPY | -1.0% | 2,274 JPY | 1,687 JPY | -1.24 | -15.48 | 9.0M | Off |
| 5 Jun 2026 | 2,161 JPY | -5.3% | 2,265 JPY | 1,686 JPY | -1.15 | -15.50 | 4.2M | Off |
| 29 May 2026 | 2,283 JPY | 0.6% | 2,250 JPY | 1,685 JPY | -1.09 | -10.52 | 45.7M | On |
| 22 May 2026 | 2,270 JPY | -2.4% | 2,227 JPY | 1,683 JPY | -1.14 | -6.94 | 26.0M | On |
| 15 May 2026 | 2,324 JPY | 1.1% | 2,205 JPY | 1,682 JPY | -1.01 | -1.70 | 26.9M | On |
| 8 May 2026 | 2,300 JPY | 4.2% | 2,180 JPY | 1,680 JPY | -0.77 | -4.61 | 25.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.